Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discovery and optimization of diarylsulfone-based dual M<sub>3</sub>-Antagonists and β<sub>2</sub>-Agonists (MABAs) as inhaled bronchodilators.

European journal of medicinal chemistry·2026
Same author

Effects of a 12-Year Nitrogen Addition Experiment on Protist Communities in a Boreal Forest, Heilongjiang Province, China.

Animals : an open access journal from MDPI·2026
Same author

Sphingosine-1-phosphate receptor modulators resensitize FLT3-ITD acute myeloid leukemia cells with NRAS mutations to FLT3 inhibitors.

Leukemia·2026
Same author

Covalent PPARγ inverse agonism by FX-909 reveals mechanistic insights into therapeutic targeting of PPARγ/RXRα-activated urothelial carcinoma.

Cell chemical biology·2026
Same author

Response of soil phosphorus fractions and bioavailability to native aquatic vegetation restoration in different types of degraded lakeside wetlands.

Journal of environmental management·2026
Same author

T<sub>2</sub> Mapping at 3 T of Cartilage and Menisci in Patients with Diabetes Mellitus.

Annals of biomedical engineering·2026

Related Experiment Video

Updated: Jul 11, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

From docking false-positive to active anti-HIV agent.

Gabriela Barreiro1, Joseph T Kim, Cristiano R W Guimarães

  • 1Department of Chemistry, Yale University, New Haven, Connecticut 06520-8107, USA.

Journal of Medicinal Chemistry
|October 9, 2007
PubMed
Summary

Virtual screening identified potential HIV-1 reverse transcriptase inhibitors. Although initial compounds were inactive, modifications led to novel anti-HIV agents, demonstrating learning from virtual screening failures.

More Related Videos

Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery
13:47

Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery

Published on: June 23, 2011

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing
07:18

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing

Published on: January 22, 2019

Related Experiment Videos

Last Updated: Jul 11, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery
13:47

Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery

Published on: June 23, 2011

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing
07:18

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing

Published on: January 22, 2019

Area of Science:

  • Medicinal Chemistry
  • Computational Chemistry
  • Virology

Background:

  • Human immunodeficiency virus-1 (HIV-1) reverse transcriptase is a key target for antiviral therapy.
  • Virtual screening is a powerful tool for identifying novel drug candidates.

Purpose of the Study:

  • To identify novel non-nucleoside inhibitors of HIV-1 reverse transcriptase (NNRTIs) using virtual screening.
  • To explore the potential of a "near-miss" compound identified through virtual screening.

Main Methods:

  • Virtual screening of the Maybridge library using similarity filtering, docking, and molecular mechanics-generalized Born/surface area (MM-GBSA) calculations.
  • Synthesis and biological evaluation of selected compounds and analogs.
  • Assay of anti-HIV activity and determination of EC50 values.

Main Results:

  • Virtual screening successfully identified known NNRTIs but failed to find active compounds from the initial library.
  • The highest-ranked compound, oxadiazole 1, was modified, leading to the synthesis of polychloro-analogs.
  • Several synthesized analogs exhibited anti-HIV activity with EC50 values as low as 310 nM.

Conclusions:

  • Virtual screening can be a valuable starting point, even when initial results are negative.
  • Computational analysis and iterative design can transform false positives into effective therapeutic agents.
  • This study highlights a successful strategy for drug discovery by learning from unsuccessful virtual screening outcomes.